Inactief instrument

Koers Fresenius Kabi Oncology Ltd

Aandelen

slotkoers NSE India S.E. Andere beurzen
- ^INR	-

AstraZeneca sells rights to anaesthetics for up to $770 million	09-06-16
Fresenius SE KGaA : Kabi sells German oncology compounding business	16-02-15
Fresenius Kabi Oncology Ltd : India revokes GSK cancer drug patent in latest Big Pharma blow	02-08-13
Fresenius Kabi Oncology Ltd : India board revokes GSK patent on breast cancer drug Tykerb	02-08-13

Managers	Titel	Leeftijd	Van
Arvind Kumar Sharma CEO	Chief Executive Officer	-	01-07-18
Rahul Sharma DFI	Director of Finance/CFO	-	-
Maria Gobbi CHM	Chairman	-	13-11-14

Besturend	Titel	Leeftijd	Van
Michael Schönhofen BRD	Director/Board Member	63	11-08-08
Nikhil Kulshreshtha BRD	Director/Board Member	-	21-07-07
Maria Gobbi CHM	Chairman	-	13-11-14

Sector

	Vaira. 1 jan.	Kapi.
REGENERON PHARMACEUTICALS, INC.	+8,96%	105 mld.
VERTEX PHARMACEUTICALS INCORPORATED	-1,43%	104 mld.
ARGENX SE	+4,40%	22,94 mld.
BIONTECH SE	-12,15%	22,34 mld.
GENMAB A/S	-4,36%	19,25 mld.
WUXI APPTEC CO., LTD.	-39,98%	17,08 mld.
BEIGENE, LTD.	-10,04%	16,96 mld.
NEUROCRINE BIOSCIENCES, INC.	+6,79%	14,16 mld.
SAREPTA THERAPEUTICS, INC.	+38,61%	12,63 mld.